# A Study in Healthy Men to Test How Zongertinib is Taken up in the Body When Taken With or Without Food

> **NCT06075277** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** zongertinib

## Key facts

- **NCT ID:** NCT06075277
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-19
- **Primary completion:** 2024-01-02
- **Final completion:** 2024-01-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06075277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06075277, "A Study in Healthy Men to Test How Zongertinib is Taken up in the Body When Taken With or Without Food". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06075277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*